| Literature DB >> 31534567 |
Andrzej P Kwiatkowski1, Gabriela Stępińska2, Edward Stanowski1, Krzysztof Paśnik1, Michal R Janik1.
Abstract
INTRODUCTION: Nowadays laparoscopic right hemicolectomy is widely accepted as the standard of care for benign and malignant colon disease. There are wide variations among laparoscopic techniques. One of the most discussed topics is the ileocolic anastomosis. There are two different techniques: intracorporeal anastomosis (IA) and extracorporeal anastomosis (EA). AIM: To compare short-term outcomes of performing intracorporeal versus extracorporeal anastomosis in laparoscopic right hemicolectomy.Entities:
Keywords: anastomosis; complications; extracorporeal; intracorporeal; laparoscopic right hemicolectomy; outcomes
Year: 2019 PMID: 31534567 PMCID: PMC6748053 DOI: 10.5114/wiitm.2019.81725
Source DB: PubMed Journal: Wideochir Inne Tech Maloinwazyjne ISSN: 1895-4588 Impact factor: 1.195
Baseline characteristics
| Parameter | IE ( | EA ( | |
|---|---|---|---|
| Age (range) [years] | 66.2 (35–87) | 68.6 (28–85) | 0.229 |
| Sex (M/F), | 31 (60.8%)/20 (39.2%) | 22 (64.7%)/12 (35.3%) | 0.820 |
| BMI (range) [kg/m2] | 27.9 (20.1–39.0) | 27.6 (18.6–41.9) | 0.668 |
| ASA (I : II : III : IV) | 5 (9.8%) : 33 (64.7%) : 13 (25.5%) : 0 | 3 (9.1%) : 22 (66.7%) : 7 (8.3%) : 1 (1.2%) | 0.739 |
| Previous abdominal surgery | 17 (33.0%) | 11 (32.3%) | 1.000 |
| Indication for surgery: | |||
| Malignant/benign pathology | 43 (84.3%)/8 (15.7%) | 28 (82.4%)/6 (17.6%) | |
Surgical outcomes
| Parameter | IE ( | EA ( | |
|---|---|---|---|
| Operative time (range) [min] | 154 (55–335) | 95 (30–210) | < 0.001 |
| Number of lymph nodes removed (range) | 14.3 (0–31) | 9.7 (2–26) | 0.117 |
| Length of hospital stay, mean ± SD (range); median | 5.3 ±3.7 (2–18); 4.0 | 11.2 ±19.8 (3–105); 5.0 | 0.022 |
| Rate of complications: | 5 (9.8%) | 9 (26.4%) | 0.071 |
| Bleeding | 1 (2%) | 2 (5.9%) | 0.561 |
| Anastomotic leak | 0 | 3 (8.8%) | 0.060 |
| Abdominal abscess | 0 | 1 (3%) | 0.400 |
| Other | 4 (7.8%) | 8 (23.5%) | 0.058 |
| Rate of reoperation | 4 (7.8%) | 5 (14.7%) | 0.474 |
| Readmission | 0 (0%) | 1 (2.9%) | 0.400 |
| Mortality | 0 | 3 (8.8%) | 0.060 |
Pathological findings. TNM staging was applied for patients with diagnosis of adenocarcinoma
| Characteristics | IE ( | EA ( | |
|---|---|---|---|
| Pathological diagnosis: | 0.382 | ||
| Adenocarcinoma | 43 (84.3%) | 28 (82.4%) | |
| Adenoma | 5 (9.8%) | 4 (11.8%) | |
| Appendicitis | 1 (1.96%) | 0 | |
| Colitis chronica | 0 | 1 (2.9%) | |
| Crohn’s disease | 1 (1.96%) | 0 | |
| GIST | 1 (1.96%) | 0 | |
| Neuroendocrine tumor | 0 | 1 (2.9%) | |
| T staging: | 0.645 | ||
| T1 | 2 (4.6%) | 2 (7.1%) | |
| T2 | 9 (20.9%) | 5 (17.9%) | |
| T3 | 29 (67.4%) | 18 (64.3%) | |
| T4 | 3 (7.0%) | 3 (10.7%) | |
| N staging: | 0.352 | ||
| N0 | 23 (53.5%) | 18 (64.3%) | |
| N1 | 10 (23.3%) | 5 (17.8%) | |
| N2 | 10 (23.3%) | 5 (17.8%) | |
| M staging: | 1.000 | ||
| M0 | 34 (79.1%) | 23 (82.1%) | |
| M1 | 9 (20.9%) | 5 (17.9%) | |
| Grading: | 0.872 | ||
| G1 | 2 (4.6%) | 2 (7.1%) | |
| G2 | 38 (88.4%) | 24 (85.7%) | |
| G3 | 3 (7.0%) | 2 (7.14%) | |
| G4 | 0 | 0 | |